Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rituxikal
- Development stage
- Unknown
- Lead developer
- Kalbio Global Medika
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
Rituxikal is a biosimilar monoclonal antibody developed and manufactured by PT Kalbio Global Medika, a subsidiary of PT Kalbe Farma in Indonesia. It contains the active ingredient rituximab, which targets the CD20 antigen on the surface of B-cell lymphocytes. By binding to CD20, it mediates B-cell lysis through mechanisms such as complement-dependent cytotoxicity (CDC) and antibody-dependent cell-mediated cytotoxicity (ADCC). Rituxikal is indicated for the treatment of Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL). It was the first monoclonal antibody product produced domestically in Indonesia, receiving marketing authorization from BPOM in December 2022 following technology transfer from mAbxience and Sinergium Biotech.
- Brand names
- Rituxikal
- Other names
- rituximab
02
Targets
Beyond the preview
Go deeper on Rituxikal.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rituxikal.